Background information. Rab11 and Rab14 are two related Rab GTPases that are believed to function in endosomal recycling and Golgi/endosome transport processes. We, and others, have identified a group of proteins that interact with Rab11 and function as Rab11 effectors, known as the Rab11-FIPs (family interacting proteins). This protein family has been sub-classified into two groups -class I FIPs [FIP2, RCP (Rab coupling protein) and Rip11 (Rab11-interacting protein)] and class II FIPs (FIP3 and FIP4).
Introduction
The compartmentalization of eurkaryotic cells requires a complex membrane-bound intracellular trafficking system in order to facilitate the transport of material from one cellular organelle to another. Central to this system is the formation of membranebound vesicles, known as endosomes, which serve as carriers of various cellular components. Receptormediated endocytosis is one of the best understood membrane transport pathway (Ullrich et al., 1996; Ang et al., 2004) .
In humans, the Rab protein family is comprised of over 60 distinct members that have emerged as major regulators of all stages of intracellular membrane trafficking events (Zerial and McBride, 2001) . They localize to the cytoplasmic face of membrane-bound organelles or vesicles, from where they regulate diverse cellular functions such as vesicle formation, transport, motility, docking and fusion (Zerial and McBride, 2001) . Rab GTPases act as molecular switches alternating between active (GTP-bound) and inactive (GDP-bound) states. In their active states, Rab proteins recruit downstream effector proteins which mediate their function (Zerial and McBride, 2001) .
The Rab11 GTPase subfamily (comprised of Rab11a, Rab11b and Rab25/Rab11c) localizes primarily to the ERC but has also been reported to localize to sorting endosomes and the TGN (trans-Golgi network) (Ullrich et al., 1996; Chen et al., 1998; Schlierf et al., 2000; Sonnichsen et al., 2000) . During interphase, Rab11 has been shown to be principally involved in controlling the slow/indirect recycling pathway and in transport from the TGN to the plasma membrane (Ullrich et al., 1996; Chen et al., 1998; Schlierf et al., 2000) . Rab11 has also been shown to play a role in the delivery of membrane to the cleavage furrow/midbody region during cell division (Horgan et al., 2004; Wilson et al., 2005) . Rab14 has been reported to localize to early/sorting endosomes and to the TGN and is proposed to play a role in the transport of material from the Golgi to early/sorting endosomes (Junutula et al., 2004) . Rab14 has also been implicated in the targeting of proteins to the apical domain of the plasma membrane in polarized epithelial cells (Kitt et al., 2008) .
Our group, and others, have identified a family of effector proteins which interact with all Rab11-subfamily members and have been termed the Rab11-FIPs or Rab11-family interacting proteins (henceforth, FIPs) (Prekeris et al., 2000; Hales et al., 2001; Lindsay et al., 2002; Wallace et al., 2002a) . These proteins have been characterized by their ability to interact with Rab11 subfamily members via a conserved 20 amino acid C-terminal RBD (Rab11-binding domain). The FIPs have been subdivided into two classes; the class I FIPs [FIP2, RCP (Rab coupling protein)/FIP1C and Rip11 (Rab11-interacting protein)/pp75/FIP5] which are characterized by the presence an N-terminal phospholipid-binding C2 domain known to be involved in membrane association (Lindsay and McCaffrey, 2004a) , and the class II FIPs (FIP3 and FIP4), which have a different domain architecture with putative calcium-binding EF-hand motifs and extensive coiled-coil domains (Prekeris et al., 2001; Wallace et al., 2002a; Horgan et al., 2007) .
It has recently been reported, in a high-throughput yeast two-hybrid screen, that Rab14 interacts with FIP2 (Fukuda et al., 2008) . Here, we have investigated this interaction further and also report and characterize two further novel Rab14-FIP interactions.
Results

Rab14 localizes to the ERC during interphase and to the cleavage furrow/midbody during cytokinesis
Determination of the subcellular distribution of a protein, particularly proteins that are involved in the control of intracellular trafficking, is a critical milestone in elucidating its function. In order to localize the Rab14 GTPase, we utilized a commercially available anti-Rab14 antibody (Ab40938, Abcam) and tested its ability to specifically detect Rab14 in A431 cells. We found that this antibody detected exogenous Rab14, but not the related Rab11a or Rab4a proteins (Supplementary Figure S1A at http://www.biolcell.org/boc/102/boc1020051add. htm). In addition, we found that prior incubation of this Rab14 antibody with recombinant GST (glutathione transferase)-fused Rab14 blocked antibody binding to endogenous Rab14 ( Supplementary Figure S1B) . Furthermore, we have also used Rab14-specific siRNA (small interfering RNA) and found that this significantly depleted the antibody signal by both immunofluorescence (Supplementary Figure S1C) and Western blotting (Supplementary Figure S1D) . These data confirmed that this antibody specifically detected Rab14.
We utilized this antibody to examine Rab14 localization with respect to that of established marker proteins of the endocytic and secretory pathways. We found, by immunofluorescence microscopy, that a significant proportion of Rab14 localized to vesicular structures that were primarily concentrated in the pericentrosomal region with some staining also visible in more peripheral cellular regions (Figure 1A) . In addition, Rab14 displayed significant, but not complete, co-localization with the TfnR [Tfn (transferrin) receptor] (23.7 + − 6.9% of all Rab14 co-localizes with TfnR) ( Figure 1A) , and endocytosed Tfn (data not shown), classical marker proteins of early/sorting endosomes and the ERC. In contrast, little co-localization was observed with EEA1 (early endosome antigen 1; 2.9 + − 0.96% of all Rab14 co-localizes with EEA1), a marker protein of sorting endosomes ( Figure 1A ). Co-localization between Rab14 and endocytosed Tfn/TfnR, but not EEA1, suggests that Rab14 may localize to the ERC. Additionally, we observed little or no co-localization between Rab14 and LBPA (lysobiophosphatidic acid), TGN46 or GM130, markers of late endosomes and the trans-and cis-Golgi respectively (data not shown).
In order to investigate further the extent of Rab14 localization to the ERC, we examined its localization in cells transfected with GFP (green fluorescent protein)-FIP3. Exogenous FIP3 has previously been shown to dramatically alter the morphology of the ERC, condensing this compartment and its known markers/cargo into a pericentrosomal location (Horgan et al., 2004; Horgan et al., 2005; Horgan et al., 2007) . Thus, overexpression of FIP3 can be used as a useful tool to demonstrate that a particular protein localizes to the ERC. We found that overexpression of FIP3 resulted in the accumulation of Rab14 on the pericentrosomal ERC when compared with non-transfected cells ( Figure 1C ). This phenotype is probably due to FIP3 condensing ERC subdomains into an exaggerated and condensed ERC structure and further suggests that Rab14 is localized to this cellular compartment. In addition, we found that Rab14 Q70L (dominant-positive GTPase-deficient mutant) significantly co-localized with Rab11a (Figure 2A , upper panel) (45.6 + − 13.3% of all Rab14 Q70L co-localizes with Rab11a), a key ERC marker protein, but not with the Golgi marker TGN46 (Figure 2A, lower panel) . Interestingly, we found limited co-localization between endogenous Rab14 and GFP-Rab11a (7.58 + − 4.0% of all Rab14 co-localizes with GFP-Rab11a), which may suggest that these two Rab proteins localize to distinct subdomains of the ERC ( Figure 1B ). We also found that Rab14 S25N (dominant-negative mutant) showed significant co-localization with TGN46 (20.7 + − 7.4% of all Rab14 S25N co-localizes with TGN46) ( Figure 2B , upper panel), but little or no co-localization with Rab11a ( Figure 2B , lower panel) or other markers of endosomal compartments (data not shown). A substantial proportion of Rab14 S25N was also cytosolic ( Figure 2B ). For this reason, the overlap between Rab14 S25N and TGN46 is better expressed as the percentage of TGN46 that co-localizes with Rab14 S25N (66.8 + − 17.7% of all TGN46 co-localizes with Rab14 S25N).
It has increasingly become apparent that certain Rab proteins localize to the cleavage furrow/midbody during cytokinesis. When we examined Rab14 localization in mitotic cells, we found that a significant proportion of Rab14 is localized to the cleavage furrow/midbody ( Figure 1D ). Similar results were observed with GFP-Rab14 (data not shown). Taken together, these data demonstrate that during interphase Rab14 localizes predominantly to the ERC and to punctate vesicular structures throughout the cell and that during cell division, Rab14 localization shifts to the ingressing cleavage furrow/midbody.
Rab14 interacts with the class I FIPs in a GTP-dependent manner
It has recently been reported, in a high-throughput yeast two-hybrid screen, that Rab14 interacts with FIP2 but was incapable of interaction with Rip11 (Fukuda et al., 2008) . To confirm and further explore the extent of Rab14/FIP interactions, we investigated the ability of Rab14 to interact with FIP proteins by far-Western blotting, yeast two-hybrid and coimmunoprecipitation methodologies. For far-Western blotting, bacterial lysates induced to express His 6 -fusions of each of the FIP proteins were resolved by SDS/PAGE and transferred to nitrocellulose. Immobilized FIPs were then challenged with recombinant GST-fused Rab14 Q70L (dominant-positive) and bound protein was detected using an anti-GST antibody. These data revealed that a direct interaction occurs between Rab14 and each of the class I FIPs, but not the class II FIPs ( Figure 3A ). Equivalent loading of His 6 -fusions were confirmed by Western blotting (Figure 3C ) and GST alone did not bind, confirming that the interactions were specific for Rab14 (data not shown). In order to investigate if this binding event is GTP-dependent, we subsequently challenged FIPs with recombinant GST-fused Rab14 S25N (dominant-negative) and observed no binding ( Figure 3B ). To independently confirm these results, Figure 4 The class I FIPs co-localize with Rab14 Q70L on the ERC A431 cells were transfected with GFP-Rab14 Q70L. At 16-18 h post-transfection, cells were processed for immunofluorescence microscopy and immunostained with antibodies against RCP, FIP2 or Rip11. Data are typical of at least three independent experiments. Scale bar, 5 μm.
we tested the ability of Rab14 Q70L and Rab14 S25N to interact with the FIPs in the yeast twohybrid system. Consistent with our far-Western results, we found that Rab14 interacts directly with the class I FIPs in a GTP-dependent manner, but not with the class II FIP proteins ( Figure 3D ). Since Rab11 has previously been shown to bind the FIPs, we performed the semi-quantitative PXG (pellet X-gal) β-galactosidase assay to compare the binding strengths of Rab11 and Rab14 for the class I FIPs. For these experiments, yeast cells were transformed with 'bait' and 'prey' plasmids containing Rab14 or Rab11 dominant-positive mutants and full-length class I FIPs. These results indicate that the Rab14/FIP interactions are of a comparable strength to those of Rab11/FIP interactions (Figure 3E ). These data confirmed that Rab14 interacts with the class I FIPs in vitro. Finally, we investigated by co-immunoprecipitation the ability of Rab14 to interact with RCP in vivo. We found that GFP-fused RCP co-immunoprecipitated endogenous Rab14 ( Figure 3F ) and that GFP-fused Rab14 wildtype co-immunoprecipitated endogenous RCP (Figure 3G) .
We next investigated the subcellular distribution of Rab14 with respect to that of the class I FIPs. For this, A431 cells were transfected with GFP-fused Rab14 Q70L and immunostained with antibodies to detect endogenous RCP, FIP2 and Rip11. We observed a significant degree of co-localization between Rab14 Q70L and all of the class I FIPs, particularly in a pericentrosomal location [51.8 + − 16.3% of all Rab14 Q70L co-localizes with RCP; 38.6 + − 10.6% of all Rab14 Q70L co-localizes with FIP2 and 46.9 + − 16.8% of all Rab14 Q70L co-localizes with Rip11] (Figure 4 ). In contrast, there appears to be no significant co-localization between Rab14 S25N with any of the class I FIPs (see Supplementary Figure S2 at http://www.biolcell.org/boc/102/boc1020051add. htm).
To investigate further the extent of co-localization between the class I FIPs and Rab14 Q70L on the ERC, we transfected A431 cells with GFPfused Rab14 Q70L and induced tubulation of the endomembrane system by treating the cells with the fungal metabolite BFA (brefeldin A), which is known to cause mixing of the TGN with the endosomal-recycling system (Reaves and Banting, 1992) . We found that Rab14 Q70L localized to an extensive membrane tubule network centred at a pericentrosomal location where it significantly colocalized with Rab11a (Supplementary Figure S3A at http://www.biolcell.org/boc/102/boc1020051add. htm). We also immunostained with antibodies against the class I FIPs and, to varying degrees, also found these proteins in the same membrane tubule network. RCP appeared to be the most extensively tubulated and co-localized strongly with Rab14 Q70L (Supplementary Figure S3B ). Rip11 appears to be less extensively tubulated but co-localization with Rab14 Q70L can also be observed in membrane tubules (Supplementary Figure S3C) . FIP2 largely retained its pericentrosomal localization pattern and strong co-localization with Rab14 Q70L can be observed at this pericentrosomal location (Supplementary Figure S3D ). Together, these data indicate that Rab14 Q70L interacts directly with the class I FIPs and that these proteins significantly co-localize at the ERC.
Rab14 binds the C-termini of the class I FIPs
The FIPs homodimerize and interact with Rab11 via a conserved 20-amino-acid C-terminal domain known as the RBD (Prekeris et al., 2001; Lindsay and McCaffrey, 2004b; Eathiraj et al., 2006; Jagoe et al., 2006) . To delineate the Rab14-binding region of RCP, we performed far-Western blotting, yeast two-hybrid and co-immunoprecipitation analyses with the RCP mutants indicated by the schematic in Figure 5 (A). We found by far-Western blotting that Rab14 Q70L specifically bound RCP 526−649 , but not RCP 2−201 , indicating that the C-terminus of RCP is essential for Rab14-binding ( Figure 5B ). To explore further these findings we investigated the ability of Rab14 Q70L to interact with RCP 85−649 and the mouse homologue of the C-terminal 67 amino acids of RCP, RCP 579−645 . We found that both of these RCP mutants are capable of binding Rab14 Q70L ( Figure 5C ). This narrowed the Rab14 interaction region to the C-terminal 67 amino acids of RCP. Additionally, we have also mapped the Rab14-binding region to the C-terminal region of Rip11 (data not shown).
To define further the Rab14-binding region of RCP, we tested the ability of Rab14 Q70L to bind RCP mutants that have single amino acid substitutions in their RBDs. Amino acid mutations in the key YID (tyrosine/isoleucine/aspartic acid) motif of the RBD of RCP has been previously shown to significantly reduce or abolish the ability of RCP to bind Rab11a (Lindsay and McCaffrey, 2004b) . To investigate the effect of these mutants on Rab14 binding, we carried out far-Western blotting with His 6 -fusions of the RBD point mutations RCP Y620F , RCP I621E and RCP D622N . Interestingly, we found that the I621E and D622N mutations blocked the ability of Rab14 to bind RCP and that the Y620F mutation significantly reduced the strength of the interaction (Figure 5D ). This finding was supported further by the inability of GFP-RCP I621E to co-immunoprecipitate Rab14 ( Figure 3F ).
Finally, we tested the ability of Rab14 to interact with RCP I621E and the equivalent Rab11-binding deficient mutants of FIP2 and Rip11 (FIP2 I481E and Rip11 I630E ) by the yeast two-hybrid system. These data illustrated that RCP I621E and Rip11 I630E cannot interact with Rab14 Q70L and that FIP2 I481E shows significantly reduced Rab14-binding ability ( Figure 5E ). Taken together, these data indicate that the class I FIPs bind to Rab14 via their C-terminal regions and that their RBDs are critical for these interactions.
Discussion
Interactions between Rab GTPases and their effector proteins are critical events in the mediation of Rab function. Here, we have identified the class I FIP proteins as the first effector targets for the Rab14 GTPase. We show that the FIPs co-localize with Rab14 on the ERC and that Rab14 and Rab11 share an overlapping binding region on class I FIPs.
Previous studies have primarily localized Rab14 to early endosomes and to the TGN (Junutula et al., 2004; Proikas-Cezanne et al., 2006; Kitt et al., 2008) . Here, we have demonstrated that in A431 cells Rab14 co-localizes with TfnR but not significantly with EEA1. We have also shown that the dominant-positive mutant of Rab14 (Rab14 Q70L) localizes significantly to a pericentrosomal location where it overlaps with Rab11a. Furthermore, Rab14 localization is condensed into the ERC upon overexpression of FIP3, and this is a hallmark of all known proteins known to localize to this compartment. Taken together, these data suggest that Rab14 is more associated with endosomes of the indirect/slow recycling pathway than was previously believed.
Our data from the present study indicates that Rab14 is partially localized to recycling vesicles of the ERC; however, there is currently no published data implicating Rab14 in plasma membrane recycling processes. Indeed, it has been shown that expression of dominant-negative Rab14 (Rab14 S25N) does not alter the uptake or recycling kinetics of Tfn through the endosomal-recycling pathway (Junutula et al., 2004; Kitt et al., 2008) . This may suggest that Rab14 plays a role on the ERC unrelated to endocytic-recycling (or at least that of the Tfn recycling pathway). It is believed that the functional GTPase cycle of Rab proteins involves the recruitment of the inactive (GDP-bound) protein onto a cellular membrane. The Rab protein is then activated by Rab GEF (guanine-nucleotide-exchange factor) activity. In its active state, the Rab protein then recruits downstream effector proteins to perform its cellular function. The Rab protein is then thought to hydrolyse its bound GTP and dissociate from the membrane (Zerial and McBride, 2001 ). Here, we have shown that Rab14 S25N localizes predominantly to the Golgi. Conversely, Rab14 Q70L localizes predominantly to the ERC. This suggests that the GTPase-deficient Q70L mutant remains concentrated at the ERC due to its inability to hydrolyse GTP. If this is indeed the case, these data suggest that Rab14 may control a trafficking step between the Golgi and the ERC. It is also possible that Rab14 plasma membrane cargo may access the ERC en route to the plasma membrane. This hypothesis is consistent with previous reports which show that some apical membrane cargo traverses endosomal compartments before accessing the plasma membrane, and that Rab14 is known to play a role in the targeting of material to the apical membrane in polarised epithelial cells (Cramm-Behrens et al., 2008; Kitt et al., 2008) .
It has become clear that delivery of membrane to the cleavage furrow is a crucial component of the membrane invagination process during cytokinesis (Strickland and Burgess, 2004) . In the present study, we have observed that a significant proportion of Rab14 localizes to the cleavage furrow/midbody region of the cell during cytokinesis. Interestingly, this localization shift to the cleavage furrow/midbody at cell division appears to be shared by a few endosomal Rab proteins, most notably Rab11, Rab21 and Rab35 (Kouranti et al., 2006; Yu et al., 2007; Pellinen et al., 2008) . The localization of Rab11 and Rab14 to the cleavage furrow and their interaction with FIP proteins may suggest that a protein complex formed between Rab14, Rab11 and FIPs may regulate membrane delivery to the midbody/cleavage furrow of the dividing cell.
Our data from the present study indicate that both Rab14 and Rab11 bind the C-terminal region of the class I FIPs and that these interactions are of comparable strength. However, the functional significance of the Rab14-FIP interactions remains elusive. It has previously been shown that the Rab6 effector, Rab6IP1, also binds Rab11, and this interaction may link Rab11 and Rab6 function at a Golgi-endosome interface (Miserey-Lenkei et al., 2007) . Similarly, it may be the case that these newly described interactions between Rab14 and the class I FIPs may couple Rab14 and Rab11 function.
Many questions remain regarding the interactions between Rab14, Rab11 and the class I FIPs, such as how is the binding of two GTPases to the same region of a single effector regulated and is there cooperation or competition between Rab14 and Rab11 with respect to FIP binding? The crystal structure of Rab11a-FIP2 demonstrates that a FIP2 homodimer presents two Rab-binding sites (Jagoe et al., 2006) . Therefore, it is possible that in vivo Rab11-FIP:FIP-Rab14 complexes could exist and function physiologically. Conversely, competition could occur between these two GTPases for FIP binding and, if this is the case, these Rab proteins would function independently of each other. Given the apparent lack of significant co-localization between GFP-Rab11 and endogenous Rab14, competition between these two Rabs is more likely than co-operation. It may also be the case that Rab11 or Rab14 GEFs might switch on their respective Rab proteins at the appropriate time and location or that Rab11-Rab14 interactions with the class I FIPs may be regulated by post-translational modifications. Indeed, although single point mutations appear to abolish the class I FIP interaction with both Rab14 and Rab11, we should not exclude the possibility that two non-identical binding sites for these Rabs exists within the C-terminal amino acids of the RBD. Indeed, some fundamental differences must exist between the RBDs of the class I and class II FIPs given that an interaction occurs between Rab14 and the class I FIPs but not the class II FIPs. Clearly, further dissection of the Rab-binding properties of the FIPs is needed to address this particular question. These are some of the key questions that are an ongoing focus of research in our laboratories.
Materials and methods
Plasmid construction
The following plasmid constructs have been described elsewhere: pEGFP-C1/FIP3 (Horgan et al., 2004) ; pTrcHisC/ FIP2 ; pTrcHisC/FIP3 (Horgan et al., 2007) ; pTrcHisA/RCP, pTrcHisA/RCP I621E , pTrcHisA/RCP Y620F and pTrcHisA/RCP D622N (Lindsay and McCaffrey, 2004b) ; pLexA/Rab11 Q70L and pGADGH/RCP (Lindsay et al., 2002) ; pGADGH/Rip11, pGADGH/FIP2 and pGADGH/FIP3 (Wallace et al., 2002a) ; pGADGH/FIP4 (Wallace et al., 2002b) ; pGADGH/RCP 85−649 and pVP16/M25 (mouse RCP 579−645 ) (Lindsay et al., 2002) ; pGADGH/RCP I621E and pGADGH/Rip11 I630E (Lindsay and McCaffrey, 2004b) ; pGADGH/FIP2 I481E (Jagoe et al., 2006) . pTrcHisC/Rip11 was generated by subcloning the Rip11 fragment from the previously described pEGFP-C1/Rip11 (Lindsay and McCaffrey, 2004a) construct into pTrcHisC (both Invitrogen).
pEGFP-Rab14 wild-type, pEGFP/Rab14 Q70L and pEGFP/Rab14 S25N were gifts from Jacques Neefjes (Cell Biology II, The Netherlands Cancer Institute, Amsterdam The Netherlands), Jean Wilson (Department of Cell Biology and Anatomy, University of Arizona, Tucson, AZ, U.S.A.) and Amira Klip (Division of Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada). pVJL10/Rab14 Q70L, pGEX-2T/Rab14 Q70L, pVJL10/Rab14 S25N and pGEX-4T1/Rab14 S25N were created by excising the 648-bp BglIIBamHI Rab14 fragments from the corresponding pEGFP plasmids and ligating into the indicated vector plasmids. pEGFP-C3/Rab11a was generated by excising the 855-bp EcoRI-PstI Rab11a wild-type fragment from the previously described pGEMRab11 construct (Wilcke et al., 2000) and ligating into pEGFP-C3 (BD Biosciences). To generate pTrcHisC/FIP4, FIP4 was amplified from an IMAGE clone (7939759) by PCR and inserted into pTrcHisC. pTrcHisC/RCP 526−649 was generated by PCR using pTrcHisA/RCP as a template and inserted into pTrcHisC. pTrcHisA/RCP 2−201 was made by the creation of a stop codon after amino acid 201 by site-directed mutagenesis on pTrcHisA/RCP.
Antibodies
Primary antibodies used were mouse monoclonal anti-transferrin receptor (Zymed), EEA1 (BD Transduction Laboratories), α-tubulin and polyhistidine (Sigma); rabbit polyclonal antihuman Rab14 (Ab40938, Abcam), GFP (Abcam), Rab11a (Zymed), GST (Sigma) and FIP2 as previously described (Lindsay and McCaffrey, 2004a) ; chicken anti-human RCP (Genway) and sheep polyclonal anti-TGN46 (Serotec). The Rip11 antibody was prepared by the immunization of a chicken with Escherichia colipurified recombinant His 6 -Rip11 protein. The resulting antiserum was affinity-purified against the immunising polypeptide (Davids Biotechnologie) and used at a dilution of 1:500. Secondary antibodies used were goat anti-mouse conjugated to Alexa Fluor ® 488 or Alexa Fluor ® 594, goat anti-chicken Alexa Fluor ® 594 (Molecular Probes) and donkey anti-rabbit conjugated to Cy3 (indocarbocyanine) (Jackson ImmunoResearch). For Western blotting, secondary antibodies used were goat anti-rabbit IRDye680 and goat anti-mouse IRDye680 (LI-COR).
Protein purification, immunoblotting, far-Western blotting, yeast two-hybrid and β-galactosidase assay
All recombinant proteins used were purified by the following method: E. coli BL21 (DE3-RIL) cells transformed with the appropriate plasmid were grown to a D 600 of between 0.8-1.5 and induced to express the recombinant protein with 0.25 mM IPTG (isopropyl β-D-thiogalactoside) for 16-20 h at 20
• C. Recombinant protein was then affinity-purified against glutathione agarose or Ni-NTA (Ni 2+ -nitrilotriacetate) agarose. For immunoblotting, proteins were resolved by SDS/PAGE and transferred on to nitrocellulose. Membranes were then blocked for 1 h in blocking solution [5% (v/v) non-fat dried skimmed milk powder in TBS; Tris-buffered saline: 10 mM Tris, pH 7.5/150 mM NaCl; Sigma]. Primary antibodies, which were diluted in blocking solution, were then incubated with the membrane for 1 h, followed by three 5 min washes in TBS-T (TBS plus 0.1% Tween-20). Membranes were subsequently probed with fluorescently labelled secondary antibodies (LI-COR) followed by three 5 min washes in TBS. Membranes were imaged using the Odyssey infrared scanning system (LI-COR). Far-Western blotting, yeast two-hybrid methodology and yeast two-hybrid PXG β-galactosidase assay was carried out as previously described (Wallace et al., 2002a; Mockli and Auerbach, 2004; .
Cell lines, plasmid transfection, immunofluorescence microscopy and quantification of co-localization
The A431 (epidermal carcinoma) human cell line was cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% (v/v) foetal bovine serum, 2 mM L-glutamine and 25 mM Hepes and grown in 5% CO 2 at 37
• C. For overexpression studies, cells were transiently transfected with plasmid constructs using Effectene (Qiagen) or Turbofect (Fermentas) as transfection reagents. Coverslips were mounted in MOWIOL (Calbiochem) and images were recorded in a temperature-controlled environment (18
• C) using a Zeiss LSM 510 META confocal microscope fitted with a 63 × /1.4 plan apochromat lens. Images were processed using the Zeiss LSM Image Browser (Carl Zeiss) and Adobe Illustrator (Adobe) software. Co-localization quantification analyses were performed using the co-localization module of the Zeiss LSM Image examiner software. For quantification of co-localization between the fluorescence signals of endogenous proteins, obtained from costained samples, a minimum of 140 randomly chosen cells were analysed. For quantification of co-localization between the fluorescence signals of overexpressed proteins, a minimum of eight randomly chosen cells were analysed. Percentage co-localization between respective sets of proteins is presented as mean values from at least two experiments + − S.D. Co-localization values were calculated by expressing the number of pixels in a given colocalization mask as a percentage of total pixels for a given fluorophore. Co-localization masks represent yellow pixels (overlapping green and red pixels) that have been extracted from the merged image.
Co-immunoprecipitation
A2780 (ovarian tumour) human cells were transfected with GFP-RCP, GFP-Rab14 or GFP alone using the Amaxa 'Nucleofector' system (solution T, programme A-23) according to the manufacturer's instructions. Cells were lysed in lysis buffer [200 mM NaCl, 75 mM Tris/HCl, pH 7, 15 mM NaF, 1.5 mM Na 3 VO 4 , 7.5 mM EDTA, 7.5 mM EGTA, 0.15% (v/v) Tween-20, 50 μg/ml leupeptin, 50 μg/ml aprotinin, 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 300 μM ALLN (Nacetyl-L-leucyl-L-leucylnorleucinal) and 30 μM PD150606] and lysates were passed three times through a 27-gauge needle and clarified by centrifugation at 10 000 g for 10 min at 4
• C.
Magnetic beads conjugated to sheep anti-mouse IgG (Dynal) were bound to mouse anti-GFP antibodies. Antibody-coated beads were incubated with lysates for 2 h at 4
• C with constant rotation. Unbound proteins were removed by extensive washing in lysis buffer, and specifically associated proteins were eluted from the beads by boiling for 10 min in Laemmli sample buffer. 
